Holmes DT - Search Results

1

Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients.

Holmes DT, Levin A, Forer B, Rosenberg F. Holmes DT, et al. Clin Chem. 2005 May;51(5):915-7. doi: 10.1373/clinchem.2004.046821. Clin Chem. 2005. PMID: 15855672 No abstract available.

2

Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia.

Holmes DT, Schick BA, Humphries KH, Frohlich J. Holmes DT, et al. Clin Chem. 2005 Nov;51(11):2067-73. doi: 10.1373/clinchem.2005.055228. Epub 2005 Sep 1. Clin Chem. 2005. PMID: 16141286

3

Nephrogenic systemic fibrosis: the story unfolds.

Prchal D, Holmes DT, Levin A. Prchal D, et al. Among authors: holmes dt. Kidney Int. 2008 Jun;73(12):1335-7. doi: 10.1038/ki.2008.157. Kidney Int. 2008. PMID: 18516057 Free article.

4

Dehydrogenase interference with enzymatic ethanol assays: forgotten but not gone.

Gharapetian A, Holmes DT, Urquhart N, Rosenberg F. Gharapetian A, et al. Among authors: holmes dt. Clin Chem. 2008 Jul;54(7):1251-2. doi: 10.1373/clinchem.2008.103853. Clin Chem. 2008. PMID: 18593969 No abstract available.

5

Spurious hyperbilirubinemia caused by naproxen.

Al Riyami N, Zimmerman AC, Rosenberg FM, Holmes DT. Al Riyami N, et al. Among authors: holmes dt. Clin Biochem. 2009 Jan;42(1-2):129-31. doi: 10.1016/j.clinbiochem.2008.09.119. Epub 2008 Oct 21. Clin Biochem. 2009. PMID: 18977340

6

Elimination of BNP by peritoneal dialysis: investigation of analytical issues.

Chiarelli G, Beaulieu M, Taylor P, Levin A, Holmes DT. Chiarelli G, et al. Among authors: holmes dt. Perit Dial Int. 2011 Mar-Apr;31(2):199-202. doi: 10.3747/pdi.2008.00279. Perit Dial Int. 2011. PMID: 21427249 No abstract available.

7

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).

Levin A, Rigatto C, Brendan B, Madore F, Muirhead N, Holmes D, Clase CM, Tang M, Djurdjev O; CanPREDDICT investigators. Levin A, et al. BMC Nephrol. 2013 Jun 11;14:121. doi: 10.1186/1471-2369-14-121. BMC Nephrol. 2013. PMID: 23758910 Free PMC article.

8

Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort.

Levin A, Rigatto C, Barrett B, Madore F, Muirhead N, Holmes D, Clase CM, Tang M, Djurdjev O; CanPREDDICT Investigators. Levin A, et al. Nephrol Dial Transplant. 2014 May;29(5):1037-47. doi: 10.1093/ndt/gft479. Epub 2013 Dec 26. Nephrol Dial Transplant. 2014. PMID: 24371297

9

A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management.

Raizman JE, Diamandis EP, Holmes D, Stowasser M, Auchus R, Cavalier E. Raizman JE, et al. Clin Chem. 2015 Aug;61(8):1022-7. doi: 10.1373/clinchem.2015.242990. Epub 2015 Jun 23. Clin Chem. 2015. PMID: 26106077 Free article. No abstract available.

10

Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.

Kim RB, Morse BL, Djurdjev O, Tang M, Muirhead N, Barrett B, Holmes DT, Madore F, Clase CM, Rigatto C, Levin A; CanPREDDICT Investigators. Kim RB, et al. Among authors: holmes dt. Kidney Int. 2016 May;89(5):1144-1152. doi: 10.1016/j.kint.2016.01.014. Epub 2016 Mar 19. Kidney Int. 2016. PMID: 27083288 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters